Clinical

Articles

While FDA recently said Novartis and AveXis did not reveal data on their $2.1 million gene thaerpy for pediatric spinal muscular atrophy until after it was approved, Novartis is defending its actions.

Novartis defends data on its $2.1 million drug

Pharma maker expands ibuprofen recall

Two major drug recalls in the last week include an expanded recall of a widely used blood pressure medication as well as over-the-counter infant ibuprofen.

Pharma makers recall 2 important drugs

FDA is asking manufacturers to immediately stop selling OTC products containing the pain reliever benzocaine (such as Orajel) for teething in infants or children.

FDA wants certain OTC teething gels off the market

Educating pediatricians in their offices, auditing their prescription patterns, and leveraging a shared electronic health record, encourages them to choose more appropriate antibiotics for children with common respiratory infections, according to a study published in the June 12 issue of the Journal of the American Medical Association.

Training, advising pediatricians in antibiotic usage improves compliance with prescription guidelines

Teenagers who received DTaP (acellular pertussis vaccine) in their first 2 years of life had a 6 times higher risk of contracting pertussis compared with those who received DTwP (whole-cell pertussis vaccine) in their first 2 years of life, according to a study online in Pediatrics.

Newer whooping cough vaccines less effective than older vaccines

The American Academy of Pediatrics (AAP) has published a policy statement to provide pediatricians with recommendations for assessing and treating Clostridium difficile infections (CDI) in children.

AAP publishes guidelines for managing pediatric C difficile infections

The 2012 vaccination schedules for children, adolescents, and adults have been released, with changes to the recommendations for meningococcal and human papillomavirus (HPV) vaccinations in children and in hepatitis B vaccinations in adults.

2012 vaccination schedules published for children, adults

Recent FDA Approvals (through December 2011) related to (Antares, Isentress, REMS)

FDA Actions in Brief January 2012 (Antares, Isentress, REMS)

The recent approval by FDA of an adult cancer therapy is 1 example of how children’s cancer research benefits patients of all ages.